高级检索
当前位置: 首页 > 详情页

Safety and Efficacy Study of PA9159 Nasal Spray for the Treatment of Seasonal Allergic Rhinitis

文献详情

编号/登记号:
注册时间:
研究开始时间:
研究结束时间:
项目类型:
本院角色:
多中心研究:
招募状态:
试验分期:
研究疾病/适应症:
研究类型:
研究负责人:
研究单位: [1]Beijing TongRen Hospital,Beijing,China [2]Anhui Palo Alto Pharmaceuticals, Inc. [3]The First Affiliated Hospital of Bengbu Medical College,Bengbu,Anhui,China [4]The Second Hospital of Anhui Medical University,Hefei,Anhui,China [5]Beijing Shijitan Hospital,Beijing,China [6]Dongfang Hospital Beijing University of Chinese Medicine,Beijing,China [7]Renmin Hospital of Wuhan University,Wuhan,Hubei,China [8]Northern Jiangsu People's Hospital,Yangzhou,Jiangsu,China [9]The Affiliated Hospital of Changchun University of Chinese Medicine,Changchun,Jilin,China [10]Tonghua Central Hospital,Tonghua,Jilin,China [11]Yanbian University Hospital(Yanbian Hospital),Yanji,Jilin,China [12]The Affiliated Hospital of Qingdao University,Qingdao,Shandong,China [13]Yantai Yuhuangding Hospital,Yantai,Shandong,China [14]Zibo Central Hospital,Zibo,Shandong,China [15]First Hospital of Shanxi Medical University,Taiyuan,Shanxi,China [16]Second Hospital of Shanxi Medical University,Taiyuan,Shanxi,China [17]Tianjin People's Hospital,Tianjin,China [18]Zhejiang Provincial People's Hospital,Hangzhou,Zhejiang,China

关键词: Seasonal Allergic Rhinitis

研究目的:
PA9159 is a highly potent novel corticosteroid. The purpose of this study is to evaluate the safety, efficacy and characteristics of population pharmacokinetics of multiple dosing of PA9159 Nasal Spray in patients with seasonal allergic rhinitis.

资源点击量:21434 今日访问量:0 总访问量:1221 更新日期:2025-02-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学附属北京同仁医院 技术支持:重庆聚合科技有限公司 地址:北京市东城区东交民巷1号(100730)